VERV Competitors & Alternatives
Compare with similar stocks in the same industry
VERV
Main StockSupply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Genomics Precision Med
Gene Editing
Top Competitors
7 stocks in| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
$40.61
-3.86%
|
$6.02B | - | 49 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$21.29
-6.75%
|
$2.44B | - | 41 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.00
+3.09%
|
$2.01B | - | 49 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$4.28
+0.24%
|
$996.55M | - | 47 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$1.91
-5.45%
|
$951.83M | - | 47 | Compare |
|
CRBU
Caribou Biosciences, Inc. Common Stock
|
$0.36
-0.86%
|
$210.46M | - | 45 | Compare |
More VERV Analysis
Data updated: Nov 16, 2026 | Industry: (SIC None)
7 stocks in this industry